The global contrast media injectors market, valued at USD 4,949 million in 2024, is projected to reach USD 8,832.8 million by 2034, growing at a compound annual growth rate (CAGR) of 5.9% over the forecast period. In 2023, the market generated USD 4,704.4 million, and is anticipated to exhibit a year-on-year growth of 5.2% in 2024.
Contrast media injectors, also known as contrast delivery systems, are vital medical devices used to introduce contrast agents or dyes into a patient’s bloodstream. These devices ensure proper circulation of the contrast media, which is crucial for achieving high-quality imaging and accurate diagnostics during procedures such as CT scans, MRIs, and angiographies.
The market’s growth is driven by the increasing need for precise diagnostic imaging in hospitals and healthcare facilities worldwide. Contrast media injectors offer several advantages, including the ability to adjust based on patient parameters and imaging protocols, optimizing both efficiency and safety in clinical practices. As their use continues to expand for disease diagnosis and monitoring, the market for these devices is expected to see sustained demand.
Key Takeaways of Contrast Media Injectors Market Study
- North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2022 and this trend is expected to continue during the forecast period
- Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region
- AI is expected to speed up the process of injecting contrast media in the forecast period
- Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period
Contrast media injectors play an essential role in hospital, they are majorly used in imaging procedures such as computed tomography scans, magnetic resonance imaging, and angiography. They are generally used before diagnostic imaging procedures like computed tomography, magnetic resonance imaging, and angiography.
These devices are efficient in delivering precise amount of contrast media into patient’s veins which provides medical professionals with enhanced image of blood vessels and tissue. Accuracy provided by this device is very important to radiologists and clinicians as it further aid them in making accurate diagnosis and treatment plans.
The contrast media injectors cover market is set to experience a significant growth of 5.9% during the forecast period. It is projected to create an incremental opportunity of USD 3,883.8 million and is predicted to rise 1.8 times the current market value through 2034.
Competitive Landscape
Key players operating in the contrast media injectors cover market are investing in development of advanced and innovative products that are more reliable and efficient. Also, many of the key players are emphasizing on making strategic collaborations and acquisition for expansion of their geographical presence and strengthening their market share.
Recent Industry Developments in Contrast Media Injectors Market:
- In November 2022, GE Healthcare signed an agreement with Ulrich Medical for offering its branded CT Motion injector, a contrast media injector in the USA.
- In December 2020, Guerbet, a specialist in development of contrast agents and solutions for medical imaging launched Contrast&Care 2.0. These new digital solution can be used for the management of contrast media injection in medical imaging centres.
Key Players of Contrast Media Injectors Industry
- Mallinckrodt
- GE Healthcare
- Bayer AG
- Ulrich GmbH & Co. KG
- Bracco Imaging S.p.A
- Medtron
- Nemoto Kyorindo Co. Ltd
- Shenzhen Anke High-tech Co. Ltd
- Sino Medical-Device Technology Co., Ltd.
- APOLLO RT Co. Ltd.
Full Report Revealed
Key Segments of Contrast Media Injectors Industry
By Product:
In terms of product, the industry is divided into device {CT injector, MRI injector, angiography injector, PET injector}, contrast media agents {gadolinium based, iodine based [iconic-water soluble agents, non-iconic water soluble agents], barium based}, consumables {contrast syringes [CT contrast syringes, MR contrast syringes, angio/interventional syringes, syringes]}, {contrast transfer sets [low pressure valve transfer sets, high pressure valve transfer sets]}, tube systems { single head tube system with drip chamber, double head tube system with drip chamber}, and others
By Application:
In terms of application, the industry is divided into cardiology, oncology, neurology, gastrointestinal and others
By End User:
In terms of end user, the industry is segregated into hospitals, ambulatory surgical centers, diagnostic imaging centers, cancer research institutes and cardiac catheterization labs
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and Middle East and Africa (MEA), have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
